logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5747.produswest2
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Export All Citations
Copyright © Médecins Sans Frontières
v2.1.5747.produswest2
Showing 1 - 10 of 10 Items
Showing 1 - 10 of 10 Items
Citations
  • Download citations in various formats (CSV, BibTeX, EndNote) for use in reference managers and bibliographies.
  • Current Page (10)
  • CSV
  • BibTeX
  • EndNote
  • All Results (10)
  • CSV
  • BibTeX
  • EndNote
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Commentary

Closing the hepatitis B birth-dose gap in Cameroon: Global evidence and policy imperatives

Akem TE
2025-10-06 • Human Vaccines and Immunotherapeutics
2025-10-06 • Human Vaccines and Immunotherapeutics

Hepatitis B virus infects an estimated 254 million people worldwide and caused 1.1 million deaths in 2022. In the WHO African Region, about 65 million people live with chronic HBV (HB...

Conference Material
|
Poster
Journal Article
|
Review
Conference Material
|
Poster
Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Research

Implementation of a chronic care unit in humanitarian settings: Lessons learned from Malakal, South Sudan

Cuenca P, Skidmore J, Adwok E, Dau S, Nggilari J,  et al.
2024-05-03 • MSF Paediatric Days 2024
2024-05-03 • MSF Paediatric Days 2024

Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission

Cooke GS, Andrieux-Meyer I, Applegate TL, Atun R, Burry J,  et al.
2019-02-01 • Lancet Gastroenterology and Hepatology
2019-02-01 • Lancet Gastroenterology and Hepatology
Viral hepatitis is a major public health threat and a leading cause of death worldwide. Annual mortality from viral hepatitis is similar to that of other major infectious diseases such a...

Integrated hepatitis B prevention in PMTCT program in Chamanculo maternity, Maputo, Mozambique

Antabak NT, Loarec A, Nguyen AP, Eliseo NDM, Molfino L,  et al.
2018-05-04 • MSF Scientific Days International 2018: Research
2018-05-04 • MSF Scientific Days International 2018: Research

Hidden dangers-prevalence of blood borne pathogens, hepatitis B, C, HIV and syphilis, among blood donors in Sierra Leone in 2016: opportunities for improvement: a retrospective, cross-sectional study

Yambasu EE, Reid AJ, Owiti P, Manzi M, Sia Murray MJ,  et al.
2017-12-31 • Pan African Medical Journal
2017-12-31 • Pan African Medical Journal
INTRODUCTION
Transmissible blood-borne infections are a serious threat to blood transfusion safety in West African countries; and yet blood remains a key therapeutic product in the c...

Treatment outcomes in a cohort of patients with chronic hepatitis B and human immunodeficiency virus co-infection in Mumbai, India

Isaakidis P, Mansoor H, Zachariah R, Da Silva E, Varghese B,  et al.
2012-08-24 • International Health
2012-08-24 • International Health
Treatment experiences with patients co-infected with human immunodeficiency virus (HIV) and hepatitis B virus (HBV) in resource-limited settings remain poorly documented. This study aime...

Adherence to nucleos(t)ide analogue therapies for chronic hepatitis B infection: a systematic review and meta-analysis

Ford NP, Scourse R, Lemoine M, Hutin Y, Bulterys M,  et al.
2018-10-01 • Hepatology Communications
2018-10-01 • Hepatology Communications
Successful treatment outcomes for chronic hepatitis B virus (HBV) infection requires high levels of adherence to treatment. We searched three databases and abstracts from two conferences...

Prevention of mother-to-child transmission of hepatitis B virus in antenatal care and maternity services, Mozambique

Loarec A, Nguyen AP, Chissano M, Madeira N, Rusch B,  et al.
2021-12-02 • Bulletin of the World Health Organization
2021-12-02 • Bulletin of the World Health Organization
OBJECTIVE
To pilot an intervention on the prevention of mother-to-child transmission (PMTCT) of hepatitis B virus (HBV) in an antenatal care and maternity unit in Maputo, Mozambique,...

Gaps in hepatitis B vaccination completion and sero-protection for people who inject drugs in Hpakant, Myanmar, 2015-2018

Yee NS, Naing AY, Cuesta JG, Das M, Dave K
2020-05-12 • Tropical Medicine and Infectious Disease
2020-05-12 • Tropical Medicine and Infectious Disease
Hepatitis B vaccination (HBV) is recommended for high-risk groups, such as people who inject drugs (PWIDs). As part of a harm reduction program by a non-governmental organization, hepati...

Providing a gateway to prevention and care for the most at-risk populations in Bhutan: is this being achieved?

Khandu L, Zachariah R, Van der Bergh R, Wangchuk D, Tshering N,  et al.
2014-03-21 • Public Health Action
2014-03-21 • Public Health Action
SETTING
Two free-standing urban human immunodeficiency virus (HIV) testing and counselling (HCT) centres in Bhutan offering services to the general population and targeting the most ...